When patients stop taking their assigned treatment in a clinical trial - whether due to side effects, lack of effectiveness, or personal...

The Imperial Clinical Trials Unit (ICTU) team had the pleasure of attending the International Clinical Trials Methodology Conference...

The US Food and Drug Administration’s (FDA) guidance document on decentralised clinical trials (DCTs) published in September 2024 is a...

Within the trial’s community, we are regularly talking about more efficient designs such as adaptive designs and decentralising elements...

The following blog represents my personal perspective and experiences within this context. I warmly welcome any different viewpoints and...